Company Novo Nordisk A/S Swiss Exchange

Company Novo Nordisk A/S Swiss Exchange

NOVOB

DK0062498333

Pharmaceuticals

Analysts' Consensus

Equities

NOVOB

DK0062498333

Pharmaceuticals

Analysts' Consensus

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Holdings

Company contact information

Group companies

Sector

Sales per Business

Sales per region

Ratings for Novo Nordisk A/S

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Other Pharmaceuticals

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Holdings

Company contact information

Group companies

Sector

Sales per Business

Sales per region

Ratings for Novo Nordisk A/S

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Other Pharmaceuticals

Delayed Swiss Exchange Other stock markets 11:36:57 2023-09-07 am EDT			5-day change	1st Jan Change
80 ^CHF	+33.33%		-.--%	-.--%

Jun. 28	India plans incentives for diabetes, obesity drug makers in 2026, government official says	RE
Jun. 28	NOVO NORDISK : UBS gives a Neutral rating	ZD

Novo Nordisk A/S specializes in the design, manufacture and marketing of pharmaceutical products. Net sales break down by family of products as follows:

- diabetes and obesity treatment products (92.6%);

- rare disease treatment products (7.4%): intended for the treatment of haemophilia, blood disorders, hormonal disorders, etc.

Net sales are distributed geographically as follows: Europe/Middle East/Africa (21.9%), the United States (54.9%), North America (3.9%), China (7.2%) and other (12.1%).

DKK in Million	2022	Weight	2023	Weight	Delta
Diabetes and Obesity Care 92.6 %	156,412	88.4 %	215,098	92.6 %	+37.52%
Rare Disease 7.4 %	20,542	11.6 %	17,163	7.4 %	-16.45%

DKK in Million	2022	Weight	2023	Weight	Delta
United States 54.9 %	84,656	47.8 %	127,534	54.9 %	+50.65%
EMEA 21.9 %	44,236	25.0 %	50,867	21.9 %	+14.99%
Rest of the World 12.1 %	25,402	14.4 %	28,078	12.1 %	+10.53%
China 7.2 %	16,209	9.2 %	16,687	7.2 %	+2.95%
Canada 3.9 %	6,451	3.6 %	9,095	3.9 %	+40.99%

Managers	Title	Age	Since
Lars Fruergaard Jorgensen CEO	Chief Executive Officer	58	90-12-31
Karsten Munk Knudsen DFI	Director of Finance/CFO	53	98-12-31
Stephen Gough CTO	Chief Tech/Sci/R&D Officer	-	15-09-30
Marcus Schindler CTO	Chief Tech/Sci/R&D Officer	57	17-12-31
Maziar Mike Doustdar COO	Chief Operating Officer	54	91-12-31
Henrik Ehlers Wulff CTO	Chief Tech/Sci/R&D Officer	54	98-12-31
Daniel Bohsen IRC	Investor Relations Contact	-	20-02-29
Tania Sabroe HRO	Human Resources Officer	47	06-12-31
Irina Ivanischeva LAW	General Counsel	-	-
Sergey Manelis PRN	Corporate Officer/Principal	-	20-07-12

Members of the board	Title	Age	Since
Sylvie Grégoire BRD	Director/Board Member	62	15-03-18
Helge Lund CHM	Chairman	62	17-03-22
Martin MacKay BRD	Director/Board Member	68	18-02-28
Laurence Debroux BRD	Director/Board Member	55	19-03-20
Kasim Kutay BRD	Director/Board Member	59	17-03-22
Andreas Fibig BRD	Director/Board Member	62	18-02-28
Henrik Poulsen BRD	Director/Board Member	57	21-03-24
Mette Bøjer Jensen BRD	Director/Board Member	49	18-03-21
Thomas Rantzau BRD	Director/Board Member	52	18-03-21
Elisabeth Christensen BRD	Director/Board Member	59	22-03-23

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	10	1,075,000,000	0	0	70.22 %
Stock B	1	3,386,519,207	3,133,044,416 ( 92.52 %)	48,091,207 ( 1.420 %)

Name	Equities	%	Valuation
Novo Holdings A/S (Investment Company) 5.610 %	190,183,000	5.610 %	25 668 M CHF
NOVO NORDISK A/S 1.449 %	49,118,207	1.449 %	6 629 M CHF
State Street Global Advisors Ltd. 0.1898 %	6,434,139	0.1898 %	868 M CHF
Sjunde AP-fonden 0.1307 %	4,431,220	0.1307 %	598 M CHF
Eleva Capital LLP 0.1278 %	4,331,421	0.1278 %	585 M CHF
MFS International Singapore Pte Ltd. 0.1179 %	3,997,109	0.1179 %	539 M CHF
Amundi Asset Management SA (Investment Management) 0.1136 %	3,850,825	0.1136 %	520 M CHF
FMR Investment Management (UK) Ltd. 0.1102 %	3,735,699	0.1102 %	504 M CHF
Eurizon Capital SGR SpA 0.1087 %	3,684,700	0.1087 %	497 M CHF
Danske Bank A/S (Investment Management) 0.1081 %	3,663,902	0.1081 %	494 M CHF

Name	Equities	%	Valuation
Novo Holdings A/S (Investment Company) 100.00 %	1,074,872,000	100.00 %	145 B CHF
ANIMA Sgr SpA 0.0197 %	211,527	0.0197 %	29 M CHF
Creutz & Partners The Art of Asset Management SA 0.009303 %	100,000	0.009303 %	13 M CHF
NS Partners SA 0.006408 %	68,876	0.006408 %	9 M CHF
Kieger AG 0.002940 %	31,596	0.002940 %	4 M CHF
Mercer Global Investments Europe Ltd. 0.002487 %	26,732	0.002487 %	4 M CHF
OLZ AG 0.001913 %	20,557	0.001913 %	3 M CHF
Swissinvest Institut für Angewandte Finanzmarktanalysen GmbH 0.000698 %	7,500	0.000698 %	1 M CHF
Claresco Finance SA 0.000484 %	5,200	0.000484 %	701 815 CHF
RAM Active Investments SA 0.000240 %	2,584	0.000240 %	348 748 CHF

Name	Equities	%	Valuation
Jennison Associates LLC 0.6219 %	21,084,614	0.6219 %	2 852 M CHF
Fidelity Management & Research Co. LLC 0.5193 %	17,604,322	0.5193 %	2 382 M CHF
Merrill Lynch International 0.4150 %	14,068,584	0.4150 %	1 903 M CHF
Fisher Asset Management LLC 0.4048 %	13,724,718	0.4048 %	1 857 M CHF
Eaton Vance Management 0.3543 %	12,011,853	0.3543 %	1 625 M CHF
Fayez Sarofim & Co. 0.3485 %	11,815,837	0.3485 %	1 598 M CHF
Renaissance Technologies LLC 0.3182 %	10,786,074	0.3182 %	1 459 M CHF
Royal Trust Corp. of Canada 0.2860 %	9,695,203	0.2860 %	1 312 M CHF
Loomis, Sayles & Co. LP 0.2611 %	8,852,532	0.2611 %	1 198 M CHF
Folketrygdfondet 0.2583 %	8,756,034	0.2583 %	1 185 M CHF

Name	Equities	%	Valuation
NOVO NORDISK A/S 1.45%	49,118,207	1.45%	6,629,209,828 $
NNIT A/S 17.50%	4,375,000	17.50%	68,770,275 $
INNATE PHARMA 12.14%	9,817,546	12.14%	26,964,577 $

Novo Nordisk A/S

Novo Allé 1

2880, Bagsværd

+45 44 44 88 88

http://www.novonordisk.com

Name	Category and Sector
Novo Nordisk India Pvt Ltd. Novo Nordisk India Pvt Ltd. Medical/Nursing ServicesHealth Services Part of Novo Nordisk A/S, Novo Nordisk India Pvt Ltd. is a leading healthcare company founded in 1923 and headquartered in Denmark. The company is based in Bengaluru, India. Novo Nordisk's purpose is to drive change to defeat diabetes and other serious chronic diseases.	Medical/Nursing Services
Velfærdsfonden for Novo Nordisk A/S	Investment Trusts/Mutual Funds
NNE A/S NNE A/S Engineering & ConstructionIndustrial Services Part of Novo Nordisk A/S, NNE A/S is a Danish company that supplies systems, consultancy and engineering services. The company is based in Soborg, Denmark.	Engineering & Construction
World Diabetes Foundation	Investment Trusts/Mutual Funds
Novo Nordisk Health Care AG Novo Nordisk Health Care AG Pharmaceuticals: MajorHealth Technology Novo Nordisk Health Care AG engages in the production and distribution of chemical and pharmaceutical products as well as articles for diagnostic and therapeutic applications. It also specializes in the research in and development of products, therapeutic methods, and display techniques primarily used in the chemical, pharmaceutical, and diagnostic fields. The company was founded on August 10, 2000 and is headquartered in Zurich, Switzerland.	Pharmaceuticals: Major
Novo Nordisk Finance (Netherlands) BV	Finance/Rental/Leasing
Novo Nordisk Region Europe A/S Novo Nordisk Region Europe A/S Financial ConglomeratesFinance Novo Nordisk Region Europe A/S holds ownership interests in other companies to undertake investment and financing activities. It offers service on an operational basis, including the placement of capital in companies and real estate. The company was founded September 14, 2001 and is headquartered in Bagsvaerd, Denmark.	Financial Conglomerates

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

1,006 DKK

Average target price

949.7 DKK

Spread / Average Target

-5.56%

Consensus

Estimates Revisions

Company calendar

	1st Jan change	Capi.
ELI LILLY AND COMPANY	+55.32%	815B
JOHNSON & JOHNSON	-6.75%	352B
MERCK & CO., INC.	+13.56%	314B
ABBVIE INC.	+10.68%	303B
ASTRAZENECA PLC	+16.09%	242B
ROCHE HOLDING AG	+2.09%	224B
NOVARTIS AG	+13.16%	218B
AMGEN INC.	+8.48%	168B
PFIZER, INC.	-2.81%	159B

Other Pharmaceuticals

Healthcare

Pharmaceuticals & Medical Research

Pharmaceuticals

Pharmaceuticals

Other Pharmaceuticals